Hydrochlorothiazide/Losartan Potassium

氢氯噻嗪/氯沙坦钾

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Losartan Potassium
Drug Alias NameHydrochlorothiazide - Losartan potassium mixt氯沙坦钾和氢氯噻嗪氯沙坦钾氢氯噻嗪Losartan Potassium/Hydrochlorothiazide氢氯噻嗪和氯沙坦钾 +[13] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertensionStroke
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1995/04/28
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsYes HydrochlorothiazideLosartan Potassium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesOrganon Usa IncMerck Sharp & Dohme Ltd
Inactive CompaniesKyushu UniversityMerck Sharp & Dohme LLCOrganon & Co
Active IndicationsHypertensionStroke
Inactive IndicationsN/A

Other Information

ATC CodeC09DA01
Related LinksKEGG